1. HBW Insight
  2. >>Health
  3. >>Business

Perrigo’s Pending OTC Launches Promising But Pandemic Precludes Pumping Guidance

 
• By Eileen Francis

A diclofenac topical analgesic is first, likely followed by a line extension for its Prevacid 24HR PPI brand. Perrigo also plans to introduce natural-based products that “leverage our expertise in Europe."

Quarterly resluts on typewriter close up

Perrigo Company PLC expects OTC product launches from its $500m pipeline that will reach the market over the next year to start during the current quarter with a diclofenac topical analgesic, likely followed by a line extension for its Prevacid 24HR proton pump inhibitor brand.

Additionally, the Dublin-based private label and store brand OTC market leader is planning to introduce natural-based products that “leverage our...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

AI Now Used By Majority Of Europeans For Preventative Health Decision Making

 
• By David Ridley

Young people are even more enthusiastically adopting artificial intelligence, notes consulting firm Simon-Kucher in its latest Better Health Report, with 81% of 18-to-28-year-olds reporting that AI has a role to play in their health-related decision making.

US FDA Program Encouraging Domestic Manufacturing May Be ‘Very Selective’

 
• By Sarah Karlin-Smith

Pharmaceutical manufacturers encouraged FDA to consider including expansions and modifications of existing US facilities in PreCheck program.

Futura Looks To Refine Eroxon Messaging To Help Sales

 
• By Tom Gallen

A strategic review of Eroxon has identified an “over-expectation" of what the product will deliver requiring a more refined marketing approach.

People On The Move: Appointments At Karo, Beiersdorf, H&BA

 
• By Tom Gallen

The latest people moves in Europe: Karo names chief transformation officer; Beiersdorf hires Derma & Health Care leader from L’Oréal; the Health & Beauty Association gets new CEO.

More from Health

Over The Counter: Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes

 
• By David Ridley

HBW Insight speaks to AESGP's governmental and public affairs manager, Luis Rhodes Baiao, about the association's Self-Care Insight and Inspire platform, which brings together inspiring self-care initiatives from across Europe.

US FDA Facility Inspections, Website Reviews Paused With FY 2026 Budget On Hold

 
• By Malcolm Spicer

Continuing work includes “for cause and certain surveillance inspections of regulated facilities” and “criminal enforcement work and certain civil investigations” as White House mulls layoffs rather than furloughs during federal government shutdown.

PAGB: UK NHS Risks Missed Opportunity If Digital Self-Care Not Urgently Prioritized

 
• By David Ridley

The NHS App should direct users to trusted, external OTC brand resources where appropriate, says PAGB in its latest report.